American BioMed launches atherectomy device:
This article was originally published in Clinica
Executive Summary
American BioMed launched its newly CE-marked OmniCath atherectomy device at the recent Medica 99 trade show in Dusseldorf. The Woodlands, Texas-based company has also received a patent by the German Federal Court for its silicone balloon catheter technology. It claims that the silicone catheter market is worth over $300 million worldwide.